Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 7, 2019; 25(33): 4985-4998
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4985
Published online Sep 7, 2019. doi: 10.3748/wjg.v25.i33.4985
Figure 3 Confirmation of LNA real-time PCR identification results of hepatitis B virus rtM204I (YIDD) variant and rtM204 (YMDD) wild type by direct sequencing.
Nucleotide bases are shown in the parenthesis. Lower case letters represent the base in a lower amount relative to the dominant variant. Bold indicates the target amino acid and bases.
- Citation: Choe WH, Kim K, Lee SY, Choi YM, Kwon SY, Kim JH, Kim BJ. Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations. World J Gastroenterol 2019; 25(33): 4985-4998
- URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4985.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i33.4985